Memorial Sloan Kettering medical oncologist Lorenzo Falchi

Lorenzo Falchi, MD

Medical Oncologist

Titles

Assistant Attending Physician

Clinical Expertise

Follicular lymphoma; Diffuse Large B-Cell Lymphoma; Marginal Zone Lymphoma; Hodgkin Lymphoma; Mantle Cell Lymphoma; Small Lymphocytic Lymphoma/Chronic Lymphocytic Leukemia; Peripheral T-Cell Lymphoma; Burkitt Lymphoma; Clinical Trials Research; Immunotherapy; Novel Therapeutic Agents; Personalized Therapy

Share

New Patient Appointments

Scheduling a visit is easy. Click below or call us to get started.

Monday through Friday, 8:00 a.m. to 6:00 p.m., (Eastern time)
Accepted Insurance Providers

Dr. Falchi accepts the following list of insurance providers. Select your insurance provider to see more details.

Aetna

Payor Type: Commercial
In Network Coverage Type(s): HMO, EPO PPO, POS, Transplant

Aetna Medicare Advantage (City of NY retirees only, starting 7/1/23)

Payor Type:
In Network Coverage Type(s): PPO

Blue Cross Blue Shield Federal Employee Program

Payor Type: Commercial
In Network Coverage Type(s): HMO, PPO

Blue Cross Blue Shield New York

Payor Type: Commercial
In Network Coverage Type(s): PPO, POS, EPO, HMO

Blue Cross Blue Shield states outside of NY/NJ

Payor Type: Commercial
In Network Coverage Type(s): HMO, EPO PPO, POS

Blue Cross Health Plus

Payor Type: Medicaid/Managed Medicaid
In Network Coverage Type(s): HMO

Carrum Health

Payor Type: Commercial
In Network Coverage Type(s): Supplemental

Cigna

Payor Type: Commercial
In Network Coverage Type(s): PPO, POS, HMO

Connecticare

Payor Type: Commercial
In Network Coverage Type(s): POS, EPO, HMO

Emblem

Payor Type: Commercial
In Network Coverage Type(s): PPO, POS, EPO, HMO

Emblem Essential

Payor Type: Medicaid/Managed Medicaid
In Network Coverage Type(s): HMO

Emblem Medicare Advantage

Payor Type:
In Network Coverage Type(s): PPO, HMO

Empire Blue Cross Medicare Advantage

Payor Type:
In Network Coverage Type(s): PPO, HMO, DSN

Empire Essential

Payor Type: Medicaid/Managed Medicaid
In Network Coverage Type(s): HMO

Empire Plan / NYSHIP (Blue Cross/UnitedHealthcare split plan)

Payor Type: Commercial
In Network Coverage Type(s): PPO

Fidelis

Payor Type: Commercial
In Network Coverage Type(s): HMO, EPO

Fidelis Managed Medicaid & HARP

Payor Type: Medicaid/Managed Medicaid
In Network Coverage Type(s): HMO

Fidelis Medicare Advantage

Payor Type:
In Network Coverage Type(s): HMO

First Health

Payor Type:
In Network Coverage Type(s): PPO

Healthfirst

Payor Type: Commercial
In Network Coverage Type(s): EPO, HMO, PPO, POS

Healthfirst Managed Medicaid

Payor Type: Medicaid/Managed Medicaid
In Network Coverage Type(s): HMO

Healthfirst Medicare Advantage

Payor Type:
In Network Coverage Type(s): HMO, PPO

Healthsmart

Payor Type: Commercial
In Network Coverage Type(s): PPO EPO

Horizon Blue Cross Blue Shield New Jersey (HMO)

Payor Type: Commercial
In Network Coverage Type(s): HMO

Horizon Blue Cross Blue Shield New Jersey (PPO)

Payor Type: Commercial
In Network Coverage Type(s): PPO

Horizon Blue Cross Blue Shield New Jersey Omnia Tier I (EPO)

Payor Type: Commercial
In Network Coverage Type(s): EPO

Horizon Blue Cross Blue Shield New Jersey Omnia Tier II (EPO)

Payor Type: Commercial
In Network Coverage Type(s): EPO

Horizon Medicare Advantage

Payor Type:
In Network Coverage Type(s): PPO, HMO

Husky CT Medicaid

Payor Type: Medicaid/Managed Medicaid
In Network Coverage Type(s): State Government

Magnacare

Payor Type: Commercial
In Network Coverage Type(s): PPO, POS, EPO

Medicare Part A&B (traditional Medicare)

Payor Type:
In Network Coverage Type(s): Federal Government

Multiplan/Beech Street/PHCS

Payor Type: Commercial
In Network Coverage Type(s): Supplemental

MVP

Payor Type: Commercial
In Network Coverage Type(s): PPO/OAP

Non-Participating Plans with Out of Network Benefits

Payor Type: Other
In Network Coverage Type(s): PPO, POS, EPO, HMO

NYC Medicare Advantage Plus for City Employees

Payor Type:
In Network Coverage Type(s): TBD

Oscar

Payor Type: Commercial
In Network Coverage Type(s): HMO/EPO

Oxford

Payor Type: Commercial
In Network Coverage Type(s): PPO, EPO

Qualcare

Payor Type: Commercial
In Network Coverage Type(s): PPO, POS, HMO

Straight NJ Medicaid

Payor Type: Medicaid/Managed Medicaid
In Network Coverage Type(s): State Government

Straight NY Medicaid

Payor Type: Medicaid/Managed Medicaid
In Network Coverage Type(s): State Government

Tricare

Payor Type: Commercial
In Network Coverage Type(s): PPO, HMO

UMR

Payor Type: Commercial
In Network Coverage Type(s): PPO, POS

United Healthcare

Payor Type: Commercial
In Network Coverage Type(s): PPO, POS, HMO

World Trade Center Health Program (WTC)

Payor Type: Commercial
In Network Coverage Type(s): State Government

Contact and Location

Locations map
Find a Convenient Location

Memorial Sloan Kettering has locations throughout New York City, Long Island, New Jersey, and Westchester. These locations offer many services, including screening, chemotherapy, and medical testing.

See all locations

About Me

Education

MD, University of Perugia

Residencies

Internal Medicine - Yale-New Haven Hospital

Fellowships

Medical Oncology - University of Perugia, Italy; Leukemia - MD Anderson Cancer Center; Hematology/Oncology - NewYork-Presbyterian Hospital/Columbia University Medical Center

Board Certifications

Internal Medicine; Hematology; Medical Oncology

As a board-certified medical oncologist and hematologist, I have been passionately dedicated to the study and treatment of blood diseases for well over a decade with a long-standing focus on the care of people with lymphoma. My practice benefits from years of experience that I gained while working at prestigious institutions.

Read more

At MSK, I am fortunate to be part of a multidisciplinary team of experts who share a deep commitment to developing effective therapies for all people with lymphoma. Our staff also provides an exceptional level of care and support for every one of our patients from the first point of contact, so that they are never alone during their time at MSK.

I am also deeply involved in conducting patient-centered research. At MSK, we offer one of the largest clinical trial portfolios for people with all types of lymphoma. I am especially interested in understanding how lymphoma interacts with the immune system. If we know how we can harness the immune system to fight lymphoma, we can develop new immunotherapies that can be used alone or in combination.

A lymphoma diagnosis can be overwhelming and terrifying. Most of my patients are naturally concerned about their future. I am convinced that the first step towards cure is defeating fear. That is why my priority is to clear up uncertainties by providing both information and education at every visit. I also believe that each person is unique, and my goal is to offer personalized care plans, while using the most effective and innovative treatments available today.

I am convinced that the first step towards cure is defeating fear. That is why my priority is to clear up uncertainties by providing both information and education at every visit.

-Dr. Falchi

Awards and Honors

  • Best Research Fellow for the Leukemia Fellowship Program, MD Anderson Cancer Center (2013)
  • Celgene Future Leaders in Hematology Award
  • American Society of Hematology Abstract Achievement Award (2018)

Colleagues

Doctors at Memorial Sloan Kettering work as teams, with specialists from all different areas. This allows us to consider all your needs together, and to give you the best possible care.

See all Lymphoma Service doctors

Clinical Trials

Research and Publications

O’Connor OA, Falchi L, Lue J, Marchi E, Kinahan C, Sawas A, Deng C, Montanari F, Amengual J, Kim HA, Rada A, Atkins L, Khan K, Reilly A, Malanga M, Francescone M, Soderquist C, Park D, Cheng B, Risueno A, Menezes D, Shustov A, Sokol L, Scotto L. Targeting the Peripheral T-cell Lymphoma (PTCL) Epigenome with Oral 5-Azacytidine and Romidepsin Produces Marked Lineage Selective Activity in Patients with Chemotherapy Resistant Disease: A Multicenter Phase 1 Experience. Blood. Published ahead of print.

Falchi L, Sawas A, Deng C, Amengual JE, Colbourn DS, Lichtenstein EA, Khan KA, Schwartz LH, O’Connor OA. High rate of complete responses to immune checkpoint inhibitors in patients with relapsed or refractory Hodgkin lymphoma previously exposed to epigenetic therapy. J Hematol Oncol. 2016 Nov 30;9(1):132.

Vitale C,* Falchi L,* (equal contribution), ten Hacken E, Gao H, Shaim H, Van Roosbroeck K, Calin G, O’Brien S, Faderl S, Wang X, Wierda WG, Rezvani K, Reuben JM, Burger JA, Keating MJ, Ferrajoli A. Ofatumumab and Lenalidomide for Patients with Relapsed or Refractory CLL: Correlation Between Responses and Immune Characteristics. Clin Cancer Res. 2016;22(10):2359-67. 

Falchi L, Keating MJ, Marom EM, Truong M, Schlette EJ, Sargent RL, Trinh L, Wang X, Smith S, Jain N, Estrov Z, O’Brien S, Lerner S, Ferrajoli A. Correlation between FDG/PET Findings, Histological Features, Clinical Characteristics and Survival in 332 Patients with Chronic Lymphocytic Leukemia. Blood. 2014;123:2783-90.

Publications on PubMed

Visit PubMed for a full listing of Dr. Falchi’s journal articles. Pubmed is an online index of research papers and other articles from the US National Library of Medicine and the National Institutes of Health.

See all on PubMed

Disclosures

Doctors and faculty members often work with pharmaceutical, device, biotechnology, and life sciences companies, and other organizations outside of MSK, to find safe and effective cancer treatments, to improve patient care, and to educate the health care community.

MSK requires doctors and faculty members to report (“disclose”) the relationships and financial interests they have with external entities. As a commitment to transparency with our community, we make that information available to the public.

Lorenzo Falchi discloses the following relationships and financial interests:

  • ADC Therapeutics
    Provision of Services
  • AbbVie
    Provision of Services
  • GenMab
    Provision of Services
  • Roche
    Provision of Services
  • Taylor & Francis Group
    Provision of Services

If you’re a patient at MSK and would like more information about your doctor’s external relationships, please talk with your doctor.

The information published here is for a specific annual disclosure period. There may be differences between information on this and other public sites as a result of different reporting periods and/or the various ways relationships and financial interests are categorized by organizations that publish such data.


This page and data include information for a specific MSK annual disclosure period (January 1, 2021 through disclosure submission in spring 2022). This data reflects interests that may or may not still exist. This data is updated annually.

Learn more about MSK’s COI policies here. For questions regarding MSK’s COI-related policies and procedures, email MSK’s Compliance Office at [email protected].


View all disclosures